Thursday, March 22, 2012 WSJ.com: Europe Home: AstraZeneca Dealt New Setback WSJ.com: Europe Home Europe Home AstraZeneca Dealt New Setback Mar 22nd 2012, 12:59 AstraZeneca suffered another setback over its top-selling antipsychotic medicine Seroquel as the U.K.'s High Court ruled that the patent for the drug is invalid. You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions Tweet